nach oben

Drugs

Erschienen in:

01.07.2002 | Therapy in Practice

Management Issues in Syphilis

verfasst von: David Pao, Beng T. Goh, Dr James S. Bingham

Erschienen in: Drugs | Ausgabe 10/2002

Einloggen, um Zugang zu erhalten

Abstract

Syphilis is a sexually transmitted infection which is systemic from the outset and has increased in incidence worldwide over the last decade. There has been concern as to whether or not co-infection with HIV can modify the clinical presentation of syphilis and, as a genital ulcer disease, it can facilitate the transmission of HIV infection. Diagnosis is based on the microscopic identification of the causative treponeme and serological testing.

Recommendations for the treatment of syphilis have been based on expert opinion, case series, some clinical trials and 50 years of clinical experience. Penicillin, given intramuscularly, is the mainstay of treatment and the favoured preparations for early infectious syphilis are benzathine penicillin as a single injection or a course of daily procaine penicillin injections for 10 to 14 days. The duration of treatment is longer for late syphilis. There has been concern that benzathine penicillin may not prevent the development of neurosyphilis but that is a rare outcome with this therapy. The main alternative to penicillin is doxycycline, but the place of azithromycin and ceftriaxone is yet to be established.

It is not necessary to carry out examination of the cerebrospinal fluid in patients with early infectious syphilis but it should be performed in those with neurological or ocular signs, psychiatric signs or symptoms, when there is evidence of treatment failure and in those who are co-infected with HIV.

Follow-up is an essential part of management and should be particularly assiduous, for at least 24 months, in those co-infected with HIV. Partner notification should be mandatory to try to contain the spread of infection.

Stokes JH, Beerman H, Ingraham NR. Modern Clinical Syphilology. 3rd ed. Philadelphia: WB Sauders, 1945: 1

Hay PE, Tam FKW, Kitchen VS, et al. Gummatous lesions in men infected with human immunodeficiency virus and syphilis. Genitourin Med 1990; 66: 374–9PubMed

World Health Organization, Department of HIV/AIDS. Global prevalence and incidence of the selected curable sexually transmitted infections: syphilis [online]. Available from URL: http://www.who.int/HIV-AIDS/STIGlobalReport/005.htm [Accessed 2002 May 13]

Lamagni TL, Hughes G, Rogers PA, et al. New cases seen in genitourinary clinics: England 1998. Commun Dis Rep 1999; 9 Suppl. 6: 1–12

Tichonova L, Borisenko K, Ward H, et al. Epidemics of syphilis in the Russian Federation: trends, origins and priorities for control. Lancet 1997; 350: 210–3PubMedCrossRef

Chen XS, Gong XD, Liang GJ, et al. Epidemiologic trends of sexually transmitted diseases in China. Sex Transm Dis 1999; 27: 143–5

Gwanzura L, Latif A, Basset M, et al. Syphilis serology and HIV infection in Harare, Zimbabwe. Sex Transm Infect 1999; 75: 426–30PubMedCrossRef

Battu VR, Homer PJ, Taylor PK, et al. Syphilis in Bristol. Lancet 1997; 350: 1100–1PubMedCrossRef

Centre for Disease Surveillance and Control. Increased transmission of syphilis in Manchester. Commun Dis Rep CDR Wkly 2000; 10: 89

10.

Centre for Disease Surveillance and Control. Increased transmission of syphilis in men who have sex with men reported from Brighton and Hove. Commun Dis Rep CDR Wkly 2000; 10: 177, 180

11.

Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 3–17PubMedCrossRef

12.

Wasserheit JN. Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 29: 61–77

13.

Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: a randomised controlled trial. Lancet 1995; 346: 530–6PubMedCrossRef

14.

Young H. Guidelines for serological testing for syphilis. Sex Transm Infect 2000; 76: 403–5PubMedCrossRef

15.

Oriel JD. The Scars of Venus. London: Springer-Verlag, 1994CrossRef

16.

Mahoney JF, Arnold RC, Harris A. Penicillin treatment of early syphilis; a preliminary report. Vener Dis Inform 1943; 24: 355–7

17.

Löwhagen GB, Johannisson G, Roupe G. Alternative treatment of early syphilis —comparison between oral penicillin V and intramuscular procaine penicillin. Eur J Sex Transm Dis 1984; 1: 159–64

18.

Center for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998; 47: (RR1): 28–49

19.

Goh B, French P. National guidelines for the management of early and late syphilis. In: Radcliffe K, Ahmed-Jushuf I, Cowan F, et al., editors. UK national guidelines on sexually transmitted infections and closely related conditions. Sex Transm Infect 1999; 75 Suppl. 1: S29-37

20.

van Voorst Vader PC, van der Meijden WI, Cairo I, et al., editors. Sexually transmitted diseases: Netherlands diagnosis and therapy guidelines 1997. Utrecht: Stichting SOA —bestrijding, 1997 [online]. Available from URL: http//www.soa.nl [Accessed 2002 May 13]

21.

Goh BT, van Voorst Vader PC. European Guideline for the management of syphilis. In:Radcliffe KW, van Voorst Vader PC, Ross JDC, et al., editors. European Sexually Transmitted Infections Management Guidelines. (IUSTI/WHO) Int J STD AIDS 2001; 12 Suppl. 3: 14–26CrossRef

22.

World Health Organisation. Sexually transmitted infections management guidelines 2001 [online] Available from URL: http://www.who.int/HIV_AIDS/STIcasemanagement/STImanagementguidelines/who_HIVAIDS_2001.01/index.htm [Accessed 2002 May 13]

23.

Tramont EC. Persistence of Treponema pallidum following penicillin G therapy. JAMA 1976; 236: 2206–7PubMedCrossRef

24.

Mohr JA, Griffiths W, Jackson R, et al. Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA 1976; 236: 2007–8CrossRef

25.

Levit F. Syphilis therapy still imperfect. JAMA 1976; 236: 2213–4PubMedCrossRef

26.

Idsøe O, Guthe T, Willcox RR. Penicillin in the treatment of syphilis. The experience of three decades. Bull World Health Organ 1972; 47: 1–68PubMed

27.

Eagle H, Fleishman R, Musselman AD. The effective concentration of penicillin in vitro and in vivo for streptococci, pneumococci and Treponema pallidum. J Bacteriol 1950; 59: 625–43PubMed

28.

Collart P, Borel L-J, Durel P. Significance of spiral organisms found after treatment in late human and experimental syphilis. Br J Vener Dis 1964; 40: 81–9PubMed

29.

Dunlop EMC. Survival of treponemes after treatment: comments, clinical conclusions and recommendations. Genitourin Med 1985; 61: 293–301PubMed

30.

Harshan V, Jayakumar W. Doxycycline in early syphilis: a long term follow-up. Indian J Dermatol 1982; 27: 119–24PubMed

31.

Faber WR, Bos JD, Tietra PJGM, et al. Treponemicidal levels of amoxycillin in cerebrospinal fluid after oral administration. Sex Transm Dis 1983; 10: 148–50PubMedCrossRef

32.

Morrison RE, Harrison SM, Tramont EC. Oral amoxycillin, an alternative treatment for neurosyphilis. Genitourin Med 1985; 61: 359–62PubMed

33.

Verdon MS, Handsfield HH, Johnson RB. Pilot study of azithromycin for treatment of primary and secondary syphilis. Clin Infect Dis 1994; 19: 486–8PubMedCrossRef

34.

Mashkilleyson AL, Gomberg MA, Mashkilleyson N, et al. Treatment of syphilis with azithromycin. Int J STD AIDS 1996; 7 Suppl. 1: 13–5PubMedCrossRef

35.

Gruber GF, Kastelan M, Cabrijan L, et al. Treatment of early syphilis with azithromycin. J Chemother 2000; 12: 240–3PubMed

36.

Ridgway GL. Quinolones in sexually tranmitted disease: state of the art. Drugs 1999; 58 Suppl. 2: 92–5PubMedCrossRef

37.

Swartz MN, Healy BP, Musher DM. Late syphilis. In: Holmes KK, Sparling PD, Mãrdh P-A, et al., editors. Sexually Transmitted Diseases. 3rd ed. New York: McGraw-Hill, 1999: 487–509

38.

St John RK. Treatment of late benign syphilis; review of the literature. J Am Vener Dis Assoc 1976; 3: 146–7

39.

Tucker HA. Penicillin in benign late and visceral syphilis. Am J Med 1948; 5: 702–8PubMedCrossRef

40.

Dattner B. Late results of penicillin therapy in neurosyphilis. Trans Am Neurol Assoc 1952; 77: 127–31

41.

Hahn RD, Webster B, Weickhardt G, et al. The results of treatment of in 1086 general paralytics, the majority of whom were followed for more than 5 years. J Chronic Dis 1958; 7: 209–27PubMedCrossRef

42.

van der Valk PGM, Kraai EJ, van Voorst Vader PC, et al. Penicillin concentrations in cerebrospinal fluid (CSF) during repository treatment regimen for syphilis. Genitourin Med 1988; 64: 223–4PubMed

43.

Yoder FW. Penicillin treatment of neurosyphilis. Are recommended dosages sufficient? JAMA 1975; 232: 270–1CrossRef

44.

Hooshmand H, Escobar MR, Kopf SW. Neurosyphilis: a study of 241 patients. JAMA 1972; 219: 726–9PubMedCrossRef

45.

Dunlop EMC, Al-Egaily SS, Houang ET. Penicillin concentrations in CSF during repository treatment for syphilis. Genitourin Med 1990; 66: 227–8PubMed

46.

Schoth PEM, Walters EC. Penicillin concentrations in serum and CSF during high-dose intravenous treatment for neurosyphilis. Neurology 1987; 37: 1214–6PubMedCrossRef

47.

Dunlop EMC, Al-Egaily SS, Houang ET. Production of treponemicidal concentration of penicillin in cerebrospinal fluids [short report]. BMJ 1981; 283: 646PubMedCrossRef

48.

Whiteside Yim C, Flynn NM, Fitzgerald FT. Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis. Antimicrob Agents Chemother 1985; 28: 347–8CrossRef

49.

Hook EW III, Baker-Zander SA, Moskovitz BL, et al. Ceftriaxone therapy for asymptomatic neurosyphilis. Case report and western blot analysis of serum and cerebrospinal fluid IgG response to therapy. Sex Transm Dis 1986; 13: 185–8PubMedCrossRef

50.

Dowell ME, Ross P, Musher D, et al. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with the human immunodeficiency virus. Am J Med 1992; 93: 481–8PubMedCrossRef

51.

Gentile JH, Viviani C, Sparo MD, et al. Syphilitic meningomyelitis treated with ceftriaxone: case report [letter]. Clin Infect Dis 1998; 26: 528PubMedCrossRef

52.

Marra C, Slatter V, Tartaglione T, et al. Evaluation of aqueous penicillin G and ceftriaxone for experimental neurosyphilis [letter]. J Infect Dis 1992; 165: 396–7PubMedCrossRef

53.

Gjestland T. The Oslo study of untreated syphilis: An epidemiologic investigation of the natural course of syphilitic infection based on a restudy of the Boeck-Bruusgaard material. Acta Derm Venereol (Stockh) 1954; 34: 34–8

54.

Sparling PF. Natural history of syphilis. In: Holmes KK, Sparling PF, Mãrdh P-A, et al., editors. Sexually Transmitted Diseases. 3rd ed. New York: McGraw-Hill, 1999: 476

55.

Wilhelmus KR, Yokoyama CM. Syphilitic episcleritis and scleritis. Am J Ophthalmol 1987; 104: 595–7PubMed

56.

Ross WH, Sutton HFS. Acquired syphilitic uveitis. Arch Ophthalmol 1980; 98: 496–8PubMedCrossRef

57.

Lukehart S, Hook E, Baker-Zander S, et al. Invasion of central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988; 109: 855–62PubMed

58.

Rolfs R, Joesoef R, Hendershot E, et al. Early syphilis treatment: a randomised trial of enhanced therapy in HIV infected and uninfected persons. N Engl J Med 1997; 337: 307–14PubMedCrossRef

59.

Hollander H. Cerebrospinal fluid abnormalities in individuals infected with human immunodeficiency virus. J Infect Dis 1988; 158: 855–8PubMedCrossRef

60.

Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 1987; 316: 1569–72PubMedCrossRef

61.

Berry CD, Hooton TM, Collier AC, et al. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in apatient with HIV infection. N Engl J Med 1987; 316: 1587–9PubMedCrossRef

62.

Augenbraun MH, Rolfs R. Treatment of syphilis, 1998: non pregnant adults. Clin Infect Dis 1999; 28 Suppl. 1: S21-8

63.

Carey L, Glesby M, Mundy L, et al. Lumbar puncture for the evaluation of latent syphilis in hospitalised patients. Arch Intern Med 1995; 155: 1657–62PubMedCrossRef

64.

Wolters EC. Review: treatment of neurosyphilis. Clin Neuropharmacol 1987; 19: 143–54CrossRef

65.

Hook EW III, Stephens J, Ennis DM. Azithromycin compared with penicillin G benzathine for the treatment of incubating syphilis: Ann Intern Med 1999; 131: 434–7PubMed

66.

Kumar B, Muralidhar S. Malignant syphilis: a review. AIDS Patient Care STDS 1998; 12: 921–5PubMedCrossRef

67.

Schofer H, Imhof M, Thoma-Greber E, et al. Active syphilis in HIV infection: a multicentre retrospective survey. Genitourin Med 1996; 72: 176–81PubMed

68.

Radolf JD, Kaplan RP. Unusual manifestation of secondary syphilis and abnormal humoral response to T. pallidum antigens in a homosexual man with asymptomatic human immunodeficiency virus infection. J Am Acad Dermatol 1988; 18: 423–8PubMedCrossRef

69.

Katz DA, Berger JR, Duncan RC. Neurosyphilis: a comprehensive study of the effects of infection with human immunodeficiency virus. Arch Neurol 1993; 50: 243–9PubMedCrossRef

70.

Brandon WR, Boulos LM, Morse A. Determining the prevalence of neurosyphilis in a cohort co-infected with HIV. Int J STD AIDS 1993; 4: 99–101PubMed

71.

Berger JR. Neurosyphilis in HIV type-1 seropositive individuals. A retroprospective study. Arch Neurol 1991; 48: 700–2PubMedCrossRef

72.

Tomerlin MJ, Holton PD, Owens JL, et al. Evaluation of neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 1994; 18: 288–94CrossRef

73.

Musher DM, Hamill RJ, Baughn RE. Effect of human immunodeficiency virus infection on the course of syphilis and on the response to treatment. Ann Intern Med 1990; 113: 872–81PubMed

74.

Hutchinson CM, Hook EW, Shepard M, et al. Altered clinical presentation of early syphilis in patients with HIV infection. Ann Intern Med 1994; 121: 94–100PubMed

75.

Steiner A, Battegay M, Greminger P, et al. HIV infection and syphilis. Case description and literature review. Schweiz Med Wochenschr 1991; 121: 67–71PubMed

76.

Margello S, Laufer H. Quartenary neurosyphilis in a Haitian man with HIV infection. Hum Pathol 1989; 20: 808–11CrossRef

77.

O’Mahony C, Rodgers C, Mendelsohn S, et al. Rapidly progressive syphilis in early HIV infection. Int J STD AIDS 1997; 8: 275–7PubMedCrossRef

78.

Carter JB, Hamill RJ, Matoba AY. Bilateral syphilitic optic neuritis in a patient with positive test for HIV [case report]. Arch Ophthalmol 1987; 105: 1485–6PubMedCrossRef

79.

Zambrano W, Perez GM, Smith JL. Acute syphilitic blindness in AIDS. J Clin Neuroophthalmol 1987; 7: 1–5PubMedCrossRef

80.

Halperin LS. Neuroretinitis due to seronegative syphilis associated with HIV. J Clin Neuroophthalmol 1992; 12: 171–2PubMed

81.

Mc Leish WM, Pulido JS, Holland S, et al. The ocular manifestations of syphilis in human immunodeficiency virus type-1 infected host. Ophthalmology 1990; 97: 196–203

82.

Dawson S, Evans BA, Lawrence AG. Benign tertiary syphilis and HIV infection. AIDS 1988; 2: 315–6PubMedCrossRef

83.

Berger JR, Waskin H, Pall L, et al. Syphilitic cerebral gumma with HIV infection. Neurology 1992; 42: 1282–7PubMedCrossRef

84.

Czelusta A, Yen-Moore A, van der Straten M, et al. An overview of sexually transmitted diseases. Part 3. Sexually transmitted diseases in HIV-infected patients. J Am Acad Dermatol 2000; 43: 409–32PubMedCrossRef

85.

Rompalo AM, Cannon RO, Quinn TC, et al. Association of biological false positive reactions with human immunodeficiency virus infection. J Infect Dis 1992; 165: 1124–6PubMedCrossRef

86.

Capoccia A, Ranieri R, Busnelli N, et al. Serological study on the prevalence of HIV, HBV infection and on the false positive reaction of VDRL in a prison. Minerva Med 1991; 82: 125–30PubMed

87.

Joyanes B, Barobia NV, Arguez JM, et al. The association of false-positive rapid plasma reagin results and HIV infection. Sex Transm Dis 1998; 25: 569–71PubMedCrossRef

88.

Marra CM, Longstreth WT, Maxwell C, et al. Resolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis: influence of concomitant HIV infection. Sex Transm Dis 1996; 23: 184–9PubMedCrossRef

89.

Telzah EE, Greenburg MS, Harrison J, et al. Syphilis treatment response in HIV-infected individuals. AIDS 1991; 5: 591–5CrossRef

90.

Yinnon AM, Coury-Doniger P, Polito R, et al. Serologic response to treatment of syphilis in patients with HIV infection. Arch Intern Med 1996; 156: 321–5PubMedCrossRef

91.

Hicks CB, Benson PM, Lupton GP, et al. Seronegative secondary syphilis in a patient infected with human immunodeficency virus (HIV) with Kaposi’s sarcoma. Ann Intern Med 1987; 107: 492–5PubMed

92.

Tikjob G, Russel M, Petersen CS, et al. Seronegative secondary syphilis in a patient with AIDS: identification of T. pallidum in a biopsy specimen. J Am Acad Dermatol 1991; 24: 506–8PubMedCrossRef

93.

Johnson PD, Graves SR, Stewart L, et al. Specific syphilis serological tests may become negative in HIV infection. AIDS 1991; 5: 419–23PubMedCrossRef

94.

Malone J, Wallace M, Hendrick B, et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. Am J Med 1995; 99: 55–63PubMedCrossRef

95.

Goeman J, Kivuvu M, Nzila N, et al. Similar serologic response to conventional therapy for syphilis among HIV-positive and HIV-negative women. Genitourin Med 1995; 71: 275–9PubMed

96.

Gourevitch M, Selwyn P, Davenny K, et al. Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med 1993; 118: 350–5PubMed

97.

Stray-Pedersen B. Cost-benefit analysis of a prenatal preventive programme against congenital syphilis. NIPH Ann 1980; 48: 57–66

98.

Benç M, Ledger WJ. Syphilis in pregnancy. Sex Transm Infect 2000; 76: 73–9CrossRef

99.

Alexander JM, Sheffied JS, Sanchez PJ, et al. Efficacy of treatment for syphilis in pregnancy. Obstet Gynecol 1999; 93: 5–8PubMedCrossRef

100.

Jackson FR, Vanderstoep EM, Knox JM, et al. Use of acqueous benzathine penicillin G in the treatment of syphilis in pregnant women. Am J Obstet Gynecol 1962; 83: 1389–92PubMed

101.

Mascola L, Pelosi R, Alexander CE. Inadequate treatment of syphilis in pregnancy. Am J Obstet Gynecol 1984; 150: 945–7PubMed

102.

Donders GGG, Desmyter J, Hooft J, et al. Apparent failure of one injection of benzathine penicillin G for syphilis during pregnancy in HIV-seronegative African women. Sex Transm Dis 1997; 24: 94–101PubMedCrossRef

103.

Gudjonsson H, Skog E. The effect of prednisolone on the Jarisch-Herxheimer reaction. Acta Dermatol Venereol 1968; 48: 15–8

104.

Fekade DF, Knox K, Melka A. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumour necrosis factor α. N Engl J Med 1996; 335: 311–5PubMedCrossRef

Titel: Management Issues in Syphilis
verfasst von: David Pao
Beng T. Goh
Dr James S. Bingham
Publikationsdatum: 01.07.2002
Verlag: Springer International Publishing
Erschienen in: Drugs / Ausgabe 10/2002
Print ISSN: 0012-6667
Elektronische ISSN: 1179-1950
DOI: https://doi.org/10.2165/00003495-200262100-00003

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Management Issues in Syphilis

Abstract

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2002

Rizatriptan

Angiotensin II Receptor Antagonists in Chronic Heart Failure

Esomeprazole

Metabolic and Additional Vascular Effects of Thiazolidinediones

Prevention of Otitis Media by Vaccination

Food-Drug Interactions